$36.23
-2.12-5.53%
At Close: -
$37.38
1.153.17%
After Hours: Jul 25, 9:24 AM EDT
15 minutes delayed
Comments
Loading...
Q32 Bio (NASDAQ:QTTB) Stock, Analyst Ratings, Price Targets, Forecasts
Q32 Bio Inc has a consensus price target of $62.25 based on the ratings of 4 analysts. The high is $100 issued by Guggenheim on June 17, 2024. The low is $45 issued by Piper Sandler on April 2, 2024. The 3 most-recent analyst ratings were released by Guggenheim, Leerink Partners, and Oppenheimer on June 17, 2024, May 21, 2024, and April 11, 2024, respectively. With an average price target of $68 between Guggenheim, Leerink Partners, and Oppenheimer, there's an implied 81.92% upside for Q32 Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Guggenheim
Leerink Partners
Oppenheimer
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Q32 Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/17/2024 | Buy Now | 167.52% | Guggenheim | Yatin Suneja | → $100 | Initiates | → Buy | Get Alert |
| 05/21/2024 | Buy Now | 44.46% | Leerink Partners | Thomas Smith | → $54 | Initiates | → Outperform | Get Alert |
| 04/11/2024 | Buy Now | 33.76% | Oppenheimer | Jay Olson | → $50 | Initiates | → Outperform | Get Alert |
| 04/02/2024 | Buy Now | 20.39% | Piper Sandler | Christopher Raymond | → $45 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Q32 Bio (QTTB) stock?
The latest price target for Q32 Bio (NASDAQ:QTTB) was reported by Guggenheim on June 17, 2024. The analyst firm set a price target for $100.00 expecting QTTB to rise to within 12 months (a possible 167.52% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Q32 Bio (QTTB)?
The latest analyst rating for Q32 Bio (NASDAQ:QTTB) was provided by Guggenheim, and Q32 Bio initiated their buy rating.
When was the last upgrade for Q32 Bio (QTTB)?
There is no last upgrade for Q32 Bio
When was the last downgrade for Q32 Bio (QTTB)?
There is no last downgrade for Q32 Bio.
When is the next analyst rating going to be posted or updated for Q32 Bio (QTTB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Q32 Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Q32 Bio was filed on June 17, 2024 so you should expect the next rating to be made available sometime around June 17, 2025.
Is the Analyst Rating Q32 Bio (QTTB) correct?
While ratings are subjective and will change, the latest Q32 Bio (QTTB) rating was a initiated with a price target of $0.00 to $100.00. The current price Q32 Bio (QTTB) is trading at is $37.38, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.